New 'smart cancer drug' designed to 'switch on' may replace chemotherapy, says govt

A groundbreaking 'smart' cancer drug, designed to selectively target and eliminate cancerous cells, has been announced by the government, offering a potential alternative to traditional chemotherapy. This innovative treatment is engineered to activate its therapeutic action exclusively within cancer cells.

The drug's design ensures that it remains dormant until it reaches its target, thereby sparing healthy cells from the damaging effects often associated with chemotherapy. This precision targeting aims to significantly reduce the debilitating side effects experienced by patients undergoing cancer treatment.

This development represents a significant advancement in oncology, promising a more effective and less toxic approach to fighting cancer. By focusing its action only where needed, the 'smart' drug could revolutionize cancer therapy, improving patient outcomes and quality of life during treatment.

The government's announcement highlights a commitment to advancing medical research and providing cutting-edge healthcare solutions. This new drug signifies hope for many patients battling cancer, offering a glimpse into a future where cancer treatment is more targeted and less burdensome.

“

The ‘smart’ cancer drug has been designed to switch on and work only inside cancer cells, sparing the healthy cells from damage.